Manal Al-Suqi

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies”.

Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies

PLoS ONE(2023)10.1371/journal.pone.0288920

N/A

0DataRank · unranked

12 citations

Yunge Zhao, Ezzat Mostafa, Manal Al-Suqi, Emily Fleischmann, Mark R. Conaway +7 more

Regadenoson Reduces Soluble Receptor for Advanced Glycation End-Products in Lung Recipients

The Annals of Thoracic Surgery(2023)10.1016/j.athoracsur.2023.03.007

N/A

0DataRank · unranked

7 citations

Urmil Dhru, Emily Fleischmann, Ezzat Mostafa, Manal Al-Suqi, Mark R. Conaway +5 more